Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pfizer Medicare Rx Outreach Gains Momentum With Share Card Network

Executive Summary

Pfizer is using its network of more than 17,000 community groups established during its "U-Share Card" program to begin implementing the company's Medicare prescription drug benefit education program, VP-Community Advocacy Forest Harper said

You may also be interested in...



Medicare Part D May Lose Long-Term Luster For Pharma

The Medicare drug benefit's positive effect on the pharmaceutical business could be short-lived, Wharton Business School Senior Fellow Stan Bernard suggested at the Pharmaceutical Marketing Congress in Philadelphia

Medicare Part D May Lose Long-Term Luster For Pharma

The Medicare drug benefit's positive effect on the pharmaceutical business could be short-lived, Wharton Business School Senior Fellow Stan Bernard suggested at the Pharmaceutical Marketing Congress in Philadelphia

Lipitor Is Medicare Rx Marketing Tool For Drug Plans, Pfizer Says

Pfizer's Lipitor is viewed by Medicare prescription drug plans as a marketing tool with which to attract beneficiaries, U.S. Pharmaceuticals President Pat Kelly said on a second quarter earnings call July 20

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS046127

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel